🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to determine the pharmacokinetics of BI 10773 and total radioactivity...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT02172274
Treatments Being Tested
The objective of this trial is to evaluate the pharmacodynamics, pharmacoki...
Status
Completed
Location
1245.15.003 Boehringer Ingelheim Investigational Site
Start Date
2009-04
Trial ID
NCT00885118
Primary objective:To investigate if BI 10773 affects the pharmacokinetics o...
Status
Completed
Location
1245.45.1 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01284621
The objectives of this study are to assess the risk of ketoacidosis, severe...
Status
Completed
Location
Abha International Private Hospital
Start Date
2018-09-26
Trial ID
NCT03764631
Treatments Being Tested
This multicenter, open-label, prospective study randomized 46 drug-naïve ad...
Status
Recruiting
Location
SNUBH
Start Date
2024-01-01
Trial ID
NCT06846411
Treatments Being Tested
GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Status
Completed
Location
Unit of Diabetes
Start Date
2018-01-15
Trial ID
NCT03918148
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2025-02-17
Trial ID
NCT07633015
Treatments Being Tested
The goal of the study is to investigate the feasibility and benefit of nove...
Status
Recruiting
Location
Magee Women's Hospital
Start Date
2024-09-17
Trial ID
NCT06260059
Treatments Being Tested
The aim is to test in T2DM patients, whether, compared to placebo, 12 weeks...
Status
Unknown
Location
University of Virginia
Start Date
2020-02-01
Trial ID
NCT04203927
Treatments Being Tested
This trial will evaluate safety and efficacy of BI 10773 in hypertensive pa...
Status
Completed
Location
1245.48.10024 Boehringer Ingelheim Investigational Site
Start Date
2011-06
Trial ID
NCT01370005